Literature DB >> 24325646

FOXE1 association with differentiated thyroid cancer and its progression.

Marissa Penna-Martinez1, Friederike Epp, Heinrich Kahles, Elizabeth Ramos-Lopez, Nora Hinsch, Martin-Leo Hansmann, Ivan Selkinski, Frank Grünwald, Katharina Holzer, Wolf O Bechstein, Stefan Zeuzem, Christian Vorländer, Klaus Badenhoop.   

Abstract

BACKGROUND: Single nucleotide polymorphisms (SNPs) near thyroid transcription factor genes (FOXE1 rs965513/NKX2-1 rs944289) have been shown to be associated with differentiated thyroid cancer (DTC) in Caucasoid populations. We investigated the role of those SNPs in German patients with DTC and also extended our analysis to tumor stages and lymphocytic infiltration of the tumors (ITL).
METHODS: Patients with DTC (n=243; papillary, PTC; follicular, FTC) and healthy controls (HC; n=270) were analyzed for the rs965513 and rs944289 SNPs.
RESULTS: The case-control analysis for rs965513 SNP showed that the genotypes "AA," "AG," and minor allele "A" were more frequent in patients with DTC than in HC (pronounced in PTC p(genotype)=0.000084, p(allele)=0.006 than FTC p(genotype)=0.29 and p(allele)=0.06). Furthermore, subgroup analysis of the DTC patients stratified for primary tumor stage (T1-T2, T3-T4), the absence or presence of regional lymph node metastases (N0, N1), for distant metastases (M0, M1), as well as for ITL, showed an association of rs965513 with stages T1-T2, T1-T3, N1, and absence of ITL. The NKX2-1 SNP rs944289, however, was not associated with DTC.
CONCLUSION: Our results confirm that the FOXE1 rs965513 SNP confers an increased risk for DTC in the German population, particularly allele "A" and the genotypes "AA" and "AG" for PTC. This increased risk was also observed in advanced tumor stages and absence of ITL, which may reflect the course of a more aggressive disease. The NKX2-1 rs944289 SNP, however, appears to play a secondary role in the development of DTC in the German population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24325646      PMCID: PMC4026307          DOI: 10.1089/thy.2013.0274

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  26 in total

1.  Reproductive factors and risk of papillary thyroid cancer in women.

Authors:  M A Rossing; L F Voigt; K G Wicklund; J R Daling
Journal:  Am J Epidemiol       Date:  2000-04-15       Impact factor: 4.897

2.  Power and sample size calculations for studies involving linear regression.

Authors:  W D Dupont; W D Plummer
Journal:  Control Clin Trials       Date:  1998-12

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility.

Authors:  Rute A Tomaz; Inês Sousa; Joana G Silva; Catarina Santos; Manuel R Teixeira; Valeriano Leite; Branca M Cavaco
Journal:  Clin Endocrinol (Oxf)       Date:  2012-12       Impact factor: 3.478

5.  Immunohistochemical analysis of thyroid-specific transcription factors in thyroid tumors.

Authors:  Ping Zhang; Hui Zuo; Yasushi Nakamura; Misa Nakamura; Tomoko Wakasa; Kennichi Kakudo
Journal:  Pathol Int       Date:  2006-05       Impact factor: 2.534

6.  The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.

Authors:  Jaroslaw Jendrzejewski; Huiling He; Hanna S Radomska; Wei Li; Jerneja Tomsic; Sandya Liyanarachchi; Ramana V Davuluri; Rebecca Nagy; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

7.  Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.

Authors:  Julius Gudmundsson; Patrick Sulem; Daniel F Gudbjartsson; Jon G Jonasson; Asgeir Sigurdsson; Jon T Bergthorsson; Huiling He; Thorarinn Blondal; Frank Geller; Margret Jakobsdottir; Droplaug N Magnusdottir; Sigurborg Matthiasdottir; Simon N Stacey; Oskar B Skarphedinsson; Hafdis Helgadottir; Wei Li; Rebecca Nagy; Esperanza Aguillo; Eduardo Faure; Enrique Prats; Berta Saez; Mariano Martinez; Gudmundur I Eyjolfsson; Unnur S Bjornsdottir; Hilma Holm; Kristleifur Kristjansson; Michael L Frigge; Hoskuldur Kristvinsson; Jeffrey R Gulcher; Thorvaldur Jonsson; Thorunn Rafnar; Hannes Hjartarsson; Jose I Mayordomo; Albert de la Chapelle; Jon Hrafnkelsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2009-02-06       Impact factor: 38.330

8.  Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer.

Authors:  Silvia Cantara; Serena Capuano; Caterina Formichi; Milena Pisu; Marco Capezzone; Furio Pacini
Journal:  Thyroid Res       Date:  2010-08-11

9.  Diagnostic and prognostic markers in differentiated thyroid cancer.

Authors:  José M Gómez Sáez
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

View more
  21 in total

1.  Common genetic variant on 14q13.3 contributes to thyroid cancer susceptibility: evidence based on 12 studies.

Authors:  JiaoJiao Zheng; Chen Li; Cong Wang; Zhilong Ai
Journal:  Mol Genet Genomics       Date:  2015-01-01       Impact factor: 3.291

2.  TITF1 and TITF2 loci variants indicate significant associations with thyroid cancer.

Authors:  Peiliang Geng; Juanjuan Ou; Jianjun Li; Yunmei Liao; Ning Wang; Ganfeng Xie; Rina Sa; Chen Liu; Lisha Xiang; Houjie Liang
Journal:  Endocrine       Date:  2015-07-25       Impact factor: 3.633

3.  Common genetic variants on FOXE1 contributes to thyroid cancer susceptibility: evidence based on 16 studies.

Authors:  Yixin Zhuang; Weixin Wu; Han Liu; Weixin Shen
Journal:  Tumour Biol       Date:  2014-04-18

Review 4.  Molecular genetics of thyroid cancer.

Authors:  Maha Rebaї; Ahmed Rebaї
Journal:  Genet Res (Camb)       Date:  2016-05-13       Impact factor: 1.588

5.  Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.

Authors:  Huiling He; Wei Li; Sandya Liyanarachchi; Mukund Srinivas; Yanqiang Wang; Keiko Akagi; Yao Wang; Dayong Wu; Qianben Wang; Victor Jin; David E Symer; Rulong Shen; John Phay; Rebecca Nagy; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

6.  Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2.

Authors:  Huiling He; Wei Li; Sandya Liyanarachchi; Jaroslaw Jendrzejewski; Mukund Srinivas; Ramana V Davuluri; Rebecca Nagy; Albert de la Chapelle
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

7.  Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer.

Authors:  Ho-Young Son; Yul Hwangbo; Seong-Keun Yoo; Sun-Wha Im; San Duk Yang; Soo-Jung Kwak; Min Seon Park; Soo Heon Kwak; Sun Wook Cho; Jun Sun Ryu; Jeongseon Kim; Yuh-Seog Jung; Tae Hyun Kim; Su-Jin Kim; Kyu Eun Lee; Do Joon Park; Nam Han Cho; Joohon Sung; Jeong-Sun Seo; Eun Kyung Lee; Young Joo Park; Jong-Il Kim
Journal:  Nat Commun       Date:  2017-07-13       Impact factor: 14.919

8.  Replication and Meta-Analysis of Common Gene Mutations in TTF1 and TTF2 with Papillary Thyroid Cancer.

Authors:  Yan Gao; Fei Chen; Shuli Niu; Shiyu Lin; Suping Li
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

9.  Clinical features of Hispanic thyroid cancer cases and the role of known genetic variants on disease risk.

Authors:  Ana P Estrada-Florez; Mabel E Bohórquez; Ruta Sahasrabudhe; Rodrigo Prieto; Paul Lott; Carlos S Duque; Jorge Donado; Gilbert Mateus; Fernando Bolaños; Alejandro Vélez; Magdalena Echeverry; Luis G Carvajal-Carmona
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

10.  rs965513 polymorphism as a common risk marker is associated with papillary thyroid cancer.

Authors:  Fang Wang; Dehui Yan; Xu Ji; Jun Han; Meijun Chen; Hong Qiao; Shaojun Zhang
Journal:  Oncotarget       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.